Novo Nordisk Foundation sets up airborne infection vaccine initiative
Pharmaceutical Technology
DECEMBER 18, 2023
The Novo Nordisk Foundation has invested Dkr1.8bn in the initiative to develop vaccines for various airborne infection diseases.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
DECEMBER 18, 2023
The Novo Nordisk Foundation has invested Dkr1.8bn in the initiative to develop vaccines for various airborne infection diseases.
Pharma Times
DECEMBER 20, 2023
The Novo Nordisk Foundation has committed $260m to establish a new state-of-the-art research and vaccine development initiative to help combat deadly airborne infections. The initiative aims to create new or improved vaccines for deadly respiratory diseases, including tuberculosis (TB) and influenza. million deaths every year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
NOVEMBER 7, 2022
A $114m diversity in clinical trials initiative supported by the Bristol Myers Squibb Foundation (BMSF) and Gilead Sciences has selected 64 physicians for awards.
Fierce Pharma
OCTOBER 9, 2023
Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers.
pharmaphorum
APRIL 26, 2024
Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic solutions to improve outcomes in the developing world.
Pharma Times
DECEMBER 20, 2023
NIVI aims to create new or improve vaccines to combat deadly airborne infections - News - PharmaTimes
pharmaphorum
JANUARY 9, 2024
Novo Nordisk Foundation has put $25m of funding into CARB-X, an initiative that aims to tackle antimicrobial resistance (AMR).
European Pharmaceutical Review
DECEMBER 18, 2023
The Novo Nordisk Foundation has committed up to DKK 1.8 billion ($260 million) to establish a state-of-the-art research and vaccine development initiative in Denmark. million deaths per year, according to the Novo Nordisk Foundation. Collectively, these diseases cause more than 2.5 There is currently no licensed GAS vaccine.
pharmaphorum
DECEMBER 19, 2023
Novo Nordisk Foundation is providing $260m in funding for an R&D initiative to find vaccines for respiratory infectious diseases like TB and flu
Drug Store News
MARCH 6, 2023
The donation supports the "Feed the Love" hunger relief campaign.
STAT
JANUARY 11, 2024
The Texas Medicaid program, after denying coverage for an initial consult to begin experimental gene therapy that could save the life of their infant son, Sufyan, now says it will cover the costs for him to be assessed in person by doctors there.
Birth Control Pharmacist
DECEMBER 13, 2023
Over the next five years, this grant will facilitate the development of the “Pharmacists Comprehensive Abortion and Reproductive Health Empowerment (Pharmacists CARE) Initiative,” aimed at significantly increasing access to medication abortion and reproductive health services in pharmacies across California.
STAT
NOVEMBER 29, 2023
The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs. Continue to STAT+ to read the full story…
STAT
JANUARY 18, 2024
Kennedy Academy for Health Careers will be revamped to create a guaranteed path to jobs at Mass General Brigham thanks to a multimillion investment from Bloomberg Philanthropies, the foundation announced Wednesday. Of that pool, the Kennedy Academy will receive an investment of $37.8
Pharma Times
MARCH 15, 2022
The initiative will catalyse discovery and early development of antiviral medicines for future pandemics
STAT
AUGUST 1, 2023
Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. Trister also led the foundation’s Covid-19 response.
ISPE
MAY 17, 2023
To address this issue and ensure the success of digital transformation, it is crucial to focus on building a solid foundation before introducing advanced features. To address this issue and ensure the success of digital transformation, it is crucial to focus on building a solid foundation before introducing advanced features.
STAT
SEPTEMBER 7, 2022
Good Therapeutics, a private company that raised just $30 million in venture financing since its 2016 foundation, said Wednesday it had signed a deal to sell itself to Roche for $250 million without ever running a clinical trial. Read the rest…
STAT
OCTOBER 25, 2022
As MacArthur Foundation fellow Jennifer Richeson noted in The Atlantic in 2020, Americans love to perpetuate narratives of racial progress , regardless of whether that narrative is aligned with reality. We saw this in a recent New York Times essay that claimed the change in Covid-19 death rates is a laudable example of the U.S.
pharmaphorum
JANUARY 19, 2021
In a remote world, customer data is more foundational than ever, and Veeva’s 2020 European Customer Reference Data Survey found 91% of organisations view customer data as a global strategic asset, while 88% said it’s essential for new product launches or sales models. Challenges and solutions for customer data integration.
pharmaphorum
SEPTEMBER 8, 2021
The Bill & Melinda Gates Foundation must have liked what it saw in an initial collaboration with Exscientia to find new antivirals for COVID-19 and related diseases. Two months after providing initial funding of $1.5 The post Gates Foundation ramps up funding to Exscientia in COVID project appeared first on.
PQA
SEPTEMBER 13, 2023
PQA has released the entire Medication Use Quality continuing education program and Medication Use Quality Certificate, which is a fully updated version of the program that was initially released in 2020. The certificate proceeds with foundational information about health equity and social determinants of health in medication use quality.
Pharmaceutical Technology
MAY 9, 2023
Ginkgo will receive an initial research payment and an aggregate total of $406m in success-based research and development payments, regulatory and commercial milestones and royalties on sales. The database offers access to several structurally bioactive molecules that will help to quickly identify lead molecules and develop new treatments.
Pharmaceutical Technology
SEPTEMBER 13, 2022
Microsoft is offering AI technology, foundational science models and capabilities through collaboration. . To expedite Novo Nordisk's research and development (R&D), Microsoft is also collaborating with the former’s data researchers and domain specialists from initial research and development regions.
pharmaphorum
JULY 11, 2022
Annie Kennedy, chief of policy, advocacy, and patient engagement at the EveryLife Foundation for Rare Diseases, tells us why the Foundation sponsored The National Economic Burden of Rare Disease Study, undertaking the challenge of examining the financial impacts of rare diseases. Intricacies and results.
STAT
MAY 3, 2023
” The enthusiasm for CAR-T has not let up since the mid-2000s, agreed Carl June, a professor at the University of Pennsylvania and a CAR-T pioneer, speaking with Sadelain and Christi Shaw, co-founder of the More Moments More Memories Foundation, on a panel about CAR-T therapy at STAT’s Breakthrough Summit in San Francisco.
European Pharmaceutical Review
JANUARY 19, 2023
Winn Diversity in Clinical Trials Award Program ( Winn Award Program ), established by the Bristol Myers Squibb Foundation (BMSF). It is no secret that the current state of clinical research does not reflect the diversity of the US population,” observed John Damonti, President, Bristol Myers Squibb Foundation (BMSF). “As
PharmExec
DECEMBER 15, 2022
The FDA tapped the Reagan-Udall Foundation to launch the initiative.
Pharmacy Is Right For Me
FEBRUARY 1, 2024
This experience sparked her curiosity about medicine, laying the foundation for her future endeavors, “During this time, my curiosity regarding medicine was peaked, I would have doctors, pharmacists, nurses, the whole gambit of staff in and out of my room because the SVT had other complications”.
PQA
FEBRUARY 15, 2024
PQA and the Patient Advocate Foundation convened a diverse group of patients and pharmacy stakeholders in 2022 to identify and prioritize patient-centered outcomes research (PCOR) topics and evidence needed to improve social determinants of health (SDOH) screening and interventions in the pharmacy setting.
Pharmafile
FEBRUARY 9, 2023
The initiative has received support from the Novo Nordisk Foundation, contributing EUR 56,000 over the next three years. read more
Pharmaceutical Technology
MAY 16, 2023
The Foundation for the National Institutes of Health (FNIH) has announced its plans to prioritise eight rare diseases to provide industry standards for manufacturing, preclinical testing and product analytical testing for gene therapy development. The BGTC was launched in October 2021, as the first AMP initiative.
STAT
MARCH 6, 2023
The vaccine was custom-made for her at the direction of a small, recently established nonprofit with roots in Massachusetts called the Jaime Leandro Foundation for Therapeutic Cancer Vaccines. Instead, the 26 patients paid the foundation to create the vaccines and provide them through the FDA’s expanded access program.
PQA
JUNE 12, 2023
Three courses, “Healthcare Quality Foundations,” “Measurement Program Foundations” and “Measuring Quality to Improve HIV Care,” are available now in the PQA Education Center. Measurement Program Foundations focus on value-based models of care where measures are implemented as part of measurement programs.
Pharmafile
DECEMBER 19, 2022
Summary: • Results of pan-European psoriasis consensus initiative, Epicensus, published in Dermatology and Therapy journal • A call-to-action framework, centered around eight key themes, has been created to inspire standard of care improvements. • This Epicensus programme was initiated and funded by UCB. Published date: 15/12/2022.
European Pharmaceutical Review
JULY 19, 2023
The data “are compelling, particularly the significant improvements observed in both depressive and anhedonic symptoms,” stated Dr Roger S McIntyre, FRCPC, Professor of psychiatry and pharmacology, University of Toronto and Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada.
ISPE
NOVEMBER 2, 2022
2022 ISPE Annual Meeting: New Chair, New Year of ISPE Initiatives. 2022 ISPE Annual Meeting: New Chair, New Year of ISPE Initiatives. One ISPE initiative is a work in progress, he said. The initiative provides growth incentives for local groups and benefits the Society overall. Foundation Update. Trudy Patterson.
European Pharmaceutical Review
NOVEMBER 22, 2023
Thomas’ NHS Foundation Trust and King’s College London, London, UK, and European Network of Gynaecological Oncological Trial (ENGOT) lead of the ATHENA trial for rucaparib.
The Checkup by Singlecare
FEBRUARY 7, 2023
In fact, more than 1 in 4 Americans struggle to afford their meds, according to a poll conducted by the Kaiser Family Foundation. A patient or their healthcare provider (in most cases, both) will need to fill out a form to initiate enrollment. That’s where patient assistance programs (PAPs) can help.
Pharma Times
JANUARY 14, 2022
Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation
Birth Control Pharmacist
DECEMBER 31, 2023
Birth Control Pharmacist, in partnership with the California Pharmacists Association and CPhA Foundation, will be providing training, technical assistance and pharmacy mini-grants to increase the number of pharmacies dispensing medication abortion care and other reproductive health services.
Hospital Pharmacy Europe
MARCH 26, 2024
Researchers and clinicians worked across three UK hospital trusts, University Hospitals Birmingham NHS Foundation Trust (UHB), Leeds Teaching Hospitals NHS Trust and Oxford University Hospitals NHS Foundation Trust, to deliver the penicillin challenges.
Pharmaceutical Technology
JUNE 8, 2023
“The ground-breaking research and intellectual property in LNP [lipid nanoparticle] design and delivery established by Professor Xu over the last decade provide a solid foundation for Hopewell to develop our own internal pipeline, initially targeting diseases of the lung while concurrently exploring the potential of our ttLNP platform for patients (..)
Pharmafile
APRIL 3, 2023
With the launch of the Partnership for Education of Health Professionals (PEP), the Novo Nordisk Foundation takes a step towards reducing inequity in health by initially targeting the education of health professionals in underserved regions in India and East Africa. read more
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content